Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106


Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7.

Nagamachi A, Matsui H, Asou H, Ozaki Y, Aki D, Kanai A, Takubo K, Suda T, Nakamura T, Wolff L, Honda H, Inaba T.

Cancer Cell. 2013 Sep 9;24(3):305-17. doi: 10.1016/j.ccr.2013.08.011.


Identification of a common microdeletion cluster in 7q21.3 subband among patients with myeloid leukemia and myelodysplastic syndrome.

Asou H, Matsui H, Ozaki Y, Nagamachi A, Nakamura M, Aki D, Inaba T.

Biochem Biophys Res Commun. 2009 May 29;383(2):245-51. doi: 10.1016/j.bbrc.2009.04.004. Epub 2009 Apr 7.


CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.

McNerney ME, Brown CD, Wang X, Bartom ET, Karmakar S, Bandlamudi C, Yu S, Ko J, Sandall BP, Stricker T, Anastasi J, Grossman RL, Cunningham JM, Le Beau MM, White KP.

Blood. 2013 Feb 7;121(6):975-83. doi: 10.1182/blood-2012-04-426965. Epub 2012 Dec 3.


Mouse Samd9l is not a functional paralogue of the human SAMD9, the gene mutated in normophosphataemic familial tumoral calcinosis.

Li Q, Guo H, Matsui H, Honda H, Inaba T, Sundberg JP, Sprecher E, Uitto J.

Exp Dermatol. 2012 Jul;21(7):554-6. doi: 10.1111/j.1600-0625.2012.01524.x.


[Significance of chromosome 7 abnormalities in myeloid malignancies].

Shi WH, Li X, Chang CK.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Dec;22(6):1739-43. doi: 10.7534/j.issn.1009-2137.2014.06.044. Review. Chinese.


Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies.

Wong JC, Zhang Y, Lieuw KH, Tran MT, Forgo E, Weinfurtner K, Alzamora P, Kogan SC, Akagi K, Wolff L, Le Beau MM, Killeen N, Shannon K.

Blood. 2010 Jun 3;115(22):4524-32. doi: 10.1182/blood-2009-07-232504. Epub 2010 Mar 16.


Evolution and divergence of the mammalian SAMD9/SAMD9L gene family.

Lemos de Matos A, Liu J, McFadden G, Esteves PJ.

BMC Evol Biol. 2013 Jun 12;13:121. doi: 10.1186/1471-2148-13-121.


A long lasting puzzle for -7/7q- syndrome.

Honda H, Inaba T.

Oncotarget. 2014 Jan 15;5(1):7-8. No abstract available.


Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse.

Li CF, MacDonald JR, Wei RY, Ray J, Lau K, Kandel C, Koffman R, Bell S, Scherer SW, Alman BA.

BMC Genomics. 2007 Apr 3;8:92.


Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders.

Joslin JM, Fernald AA, Tennant TR, Davis EM, Kogan SC, Anastasi J, Crispino JD, Le Beau MM.

Blood. 2007 Jul 15;110(2):719-26. Epub 2007 Apr 9.


Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice.

Chen TH, Kambal A, Krysiak K, Walshauser MA, Raju G, Tibbitts JF, Walter MJ.

Blood. 2011 Feb 3;117(5):1530-9. doi: 10.1182/blood-2010-06-293167. Epub 2010 Dec 1.


Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias.

Fischer K, Fröhling S, Scherer SW, McAllister Brown J, Scholl C, Stilgenbauer S, Tsui LC, Lichter P, Döhner H.

Blood. 1997 Mar 15;89(6):2036-41.


Candidate gene isolation and comparative analysis of a commonly deleted segment of 7q22 implicated in myeloid malignancies.

Kratz CP, Emerling BM, Donovan S, Laig-Webster M, Taylor BR, Thompson P, Jensen S, Banerjee A, Bonifas J, Makalowski W, Green ED, Le Beau MM, Shannon KM.

Genomics. 2001 Oct;77(3):171-80.


-7/7q- syndrome in myeloid-lineage hematopoietic malignancies: attempts to understand this complex disease entity.

Honda H, Nagamachi A, Inaba T.

Oncogene. 2015 May 7;34(19):2413-25. doi: 10.1038/onc.2014.196. Epub 2014 Jul 7. Review.


TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele.

Bacher U, Weissmann S, Kohlmann A, Schindela S, Alpermann T, Schnittger S, Kern W, Haferlach T, Haferlach C.

Br J Haematol. 2012 Jan;156(1):67-75. doi: 10.1111/j.1365-2141.2011.08911.x. Epub 2011 Oct 24.


MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.

Chen C, Liu Y, Rappaport AR, Kitzing T, Schultz N, Zhao Z, Shroff AS, Dickins RA, Vakoc CR, Bradner JE, Stock W, LeBeau MM, Shannon KM, Kogan S, Zuber J, Lowe SW.

Cancer Cell. 2014 May 12;25(5):652-65. doi: 10.1016/j.ccr.2014.03.016. Epub 2014 May 1.


Childhood monosomy 7: epidemiology, biology, and mechanistic implications.

Luna-Fineman S, Shannon KM, Lange BJ.

Blood. 1995 Apr 15;85(8):1985-99. Review. No abstract available.


The Samd9L gene: transcriptional regulation and tissue-specific expression in mouse development.

Jiang Q, Quaynor B, Sun A, Li Q, Matsui H, Honda H, Inaba T, Sprecher E, Uitto J.

J Invest Dermatol. 2011 Jul;131(7):1428-34. doi: 10.1038/jid.2011.61. Epub 2011 Mar 17.


Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases.

Le Beau MM, Espinosa R 3rd, Davis EM, Eisenbart JD, Larson RA, Green ED.

Blood. 1996 Sep 15;88(6):1930-5.


Deletions of CDKN1B and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities.

Andreasson P, Johansson B, Arheden K, Billström R, Mitelman F, Höglund M.

Genes Chromosomes Cancer. 1997 Jun;19(2):77-83.

Items per page

Supplemental Content

Write to the Help Desk